Klaus Dembowsky

Hohenstein Institute — Germany

Medicine · Health Sciences

27h-index3.4kcitations86works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemokine receptors and signaling(25), Neuroscience of respiration and sleep(19), Heart Rate Variability and Autonomic Control(11), Nitric Oxide and Endothelin Effects(7), Immunotherapy and Immune Responses(6)

Publications84 total

Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention
Journal of Molecular Medicine·2025Open Access
Supplemental Figure 4 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Table 1-3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 4 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 7 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 6 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Table 1-3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 7 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Data from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Data from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 6 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023Open Access
Characterizing and targeting CD44v6+ cells in liver carcinoma
Journal of Hepatology·2022
C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function
Circulation·2019· 129 citedOpen Access
First-in-human, first-in-class study of the CD44v6 inhibitor AMC303 as monotherapy in patients with advanced epithelial tumors
Annals of Oncology·2018· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

J. Czachurski(17), H. Seller(17), Éric Chevalier(6), Bárbara Romagnoli(5), Heiner Apeler(4), Elisabeth Perzborn(4), Matthias Schramm(4), Klaus Amendt(4), Garry J. Douglas(4), Cristina Alonso‐Alija(3), Torsten Minuth(3), Werner Schroeder(3), Elke Stahl(3), Johannes‐Peter Stasch(3), Glenn E. Dale(3), Darja Karpova(3), Eliza Wiercinska(3), Halvard Bönig(3), A. Boczek‐Funcke(3), Heinz‐Joachim Häbler(3)